Cholesterol lowering: perspectives on the 4S and West of Scotland studies.
Olin
J W
JW
Department of Vascular Medicine, The Cleveland Clinic Foundation, OH, USA.
D000328:Adult; D000368:Aged; D000818:Animals; D000924:Anticholesteremic Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D008078:Cholesterol, LDL / Q000187:drug effects; D003327:Coronary Disease / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008148:Lovastatin / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000139:chemically induced; D017035:Pravastatin / Q000494:pharmacology* / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D051381:Rats; D012307:Risk Factors; D012537:Scandinavian and Nordic Countries; D012606:Scotland; D019821:Simvastatin
D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D008148:Lovastatin; D019821:Simvastatin; D017035:Pravastatin